Our Background

Excellence built from a unique heritage

Today, Beactica Therapeutics is setting the pace in the cancer drug development landscape, with a strong focus on leveraging synthetic lethality to develop novel therapeutics for genetically defined cancers. This position at the forefront of the field, is rooted in Beactica’s unique heritage spanning decades of research and industrial development.

This exceptional track record – in combination with the team's dedication to scientific excellence – has enabled Beactica to steadily advance its position in the pharmaceutical R&D value chain. Today, our vision is to become a clinical-stage precision oncology company with a pipeline of breakthrough therapeutics against genetically defined cancers. Read more about our pipeline here.

Stay Updated

Sign up for the Beactica newsletter to receive our latest news and updates